Table 1 Details and schedule of saMS trial assessment procedures
Measures administered | Baseline (week 0) | Mid-therapy (week 5) | Post-therapy (week 15) | 6 month follow-up (week 26) | 12 month follow-up (week 52) |
|---|---|---|---|---|---|
Demographics | X | - | - | - | - |
Detailed MS questions-(date of diagnosis, time since symptoms started, type of MS, recent and current relapses, treatment for depression, supplements or alternative therapies, participation in MS organizations) | X | - | - | - | - |
Brief MS questions (recent changes in medication, interventions, recent and current relapses) | - | - | X | X | X |
Expectations/preferences for therapy | X | - | - | - | - |
Global improvement and satisfaction ratings | - | - | X | - | - |
Feedback on CBT manual/strategies | - | - | X | - | - |
Continuation of use of CBT | - | - | - | X | X |
General Health Questionnaire (GHQ-12 [41]) | X | X | X | X | X |
Work and Social Adjustment Scale (WSAS [43]) | X | X | X | X | X |
Beliefs about Emotions Scale (BES; Rimes & Chalder; in preparation) | X | X | X | X | X |
Significant Others Scale (SOS [49]) | X | - | X | X | X |
Acceptance of Chronic Health Conditions Scale (ACHC [45]) | X | X | X | X | X |
Psychological Vulnerability Scale (PVS [46]) | X | X | X | X | X |
Brief Illness Perception Questionnaire (B-IPQ [48]) | X | X | X | X | X |
Cognitive and Behavioural Responses to Symptoms Questionnaire (CBRSQ; Moss-Morris, Chalder, Skerrett & Baldwin, in preparation) | X | X | X | X | X |
Client Service Receipt Inventory (CSRI [51]) | X | - | - | X | X |
EuroQoL (EQ5D [44]) | X | - | - | X | X |
Self-report Expanded Disability Status Scale (EDSS [50]) | X | - | - | - | X |